Overview

BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis

Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the long-term safety and tolerability of BIIB023 in participants with lupus nephritis (LN).
Phase:
Phase 2
Details
Lead Sponsor:
Biogen
Treatments:
Mycophenolic Acid